Median Technologies SA (ALMDT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Median Technologies SA (ALMDT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6374
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed services and investigator site network services. Its imaging services include regulations compliance, project management, data management and quality control, biostatistics and data analysis, and IT services. Median’s clinical trial services comprise imaging protocol design, site training and management, radiological review, imaging biomarkers, image analysis and reporting, and others. The company develops iBiopsy, a phenomics platform designed to acquire, index, and analyze individual phenotypes. It markets its solutions to pharmaceutical companies, healthcare institutions, hospitals, and cancer clinics. The company has operations in France and the US. Median is headquartered in Valbonne, France.

Median Technologies SA (ALMDT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Median Technologies SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Median Technologies SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Median Technologies SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Median Technologies SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Median Technologies SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Median Technologies SA, Medical Equipment, Deal Details 11
Venture Financing 11
MEDIAN Technologies Secures USD0.67 Million in Venture Funding 11
Partnerships 12
Median Technologies Enters into Agreement with Nice University 12
Median Technologies Enters into Research Agreement with Xingtai People’s Hospital 13
Median Technologies Partners with Microsoft 14
Median Technologies Partners with START 15
Equity Offering 16
Median Technologies Raises USD21.8 Million in Private Placement of Shares 16
Median Technologies Raises USD22 Million in Private Placement of Shares 17
Median Technologies Raises USD26.5 Million in Private Placement of Units 19
Median Technologies SA – Key Competitors 21
Median Technologies SA – Key Employees 22
Median Technologies SA – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Strategy And Business Planning 24
Mar 12, 2018: Median Technologies and the Nice University Hospital (CHU De Nice) Announce Agreement to Advance Lung Cancer Screening with Artificial Intelligence 24
Jun 22, 2017: Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials 25
Financial Announcements 26
Feb 21, 2018: Median Technologies Announces Preliminary Full Year 2017 Unaudited Financial Results 26
Oct 10, 2017: Median Technologies: H1 2017 results: half-year marked by major investments to structure the company and prepare for the future 27
Apr 12, 2017: Median Technologies Reports Full Year 2016 Financial Results 29
Corporate Communications 31
Jul 12, 2018: Median Technologies Receives the Forbes 2018 Futur40 Award and Special Recognition Prize for the “Health-Life Sciences” Company Category 31
May 24, 2018: Median Technologies Appoints Dr. Yan Liu as Medical Director, Europe 32
Nov 09, 2017: Median Technologies Appoints Dr. Peter Bannister as Chief Technology Officer 33
Oct 26, 2017: Median Technologies strengthens its medical leadership with the appointment of Dr. Loan Hoang-Sayag as Chief Medical Officer and the appointment of Dr. Fabien Ricard as Medical Director, North America 34
Oct 19, 2017: Median Technologies Appoints Vivian Wang as General Manager, China and Takashi Hayashi as Managing Director, Japan 35
Product News 36
Dec 14, 2017: Median Technologies Launches iSee- a Comprehensive Technology Platform to Enhance Medical Imaging Analysis in Clinical Trials 36
Nov 14, 2017: Median Technologies to Present at Medidata NEXT Global 2017 to Discuss How New Technologies Can Optimize Image Management in Clinical Trial 37
Nov 07, 2017: Median Technologies to Present at Medidata NEXT Global 2017 to Discuss How New Technologies Can Optimize Image Management in Clinical Trials 38
Oct 17, 2017: Median Technologies to Attend The Liver Meeting of The American Association for the Study of Liver Diseases to Be Held October 20-24, 2017 in Washington, DC, USA 39
Sep 06, 2017: Median Technologies to Attend the ESMO 2017 Congress, September 8-12, 2017, Madrid, Spain 40
May 31, 2017: Median Technologies to attend the 2017 ASCO Annual Meeting, June 2-6, 2017, McCormick Place, Chicago, IL, USA 41
Other Significant Developments 42
Apr 26, 2018: Median Technologies launches ImageBank 42
Nov 28, 2017: Median Technologies inks a collaboration agreement with Memorial Sloan Kettering Cancer Center for a study dealing with prostate cancer 43
Oct 31, 2017: Median Technologies adds MediScan to its product portfolio 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Median Technologies SA, Medical Equipment, Key Facts, 2017 2
Median Technologies SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Median Technologies SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Median Technologies SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Median Technologies SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Median Technologies SA, Deals By Market, 2012 to YTD 2018 9
Median Technologies SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MEDIAN Technologies Secures USD0.67 Million in Venture Funding 11
Median Technologies Enters into Agreement with Nice University 12
Median Technologies Enters into Research Agreement with Xingtai People’s Hospital 13
Median Technologies Partners with Microsoft 14
Median Technologies Partners with START 15
Median Technologies Raises USD21.8 Million in Private Placement of Shares 16
Median Technologies Raises USD22 Million in Private Placement of Shares 17
Median Technologies Raises USD26.5 Million in Private Placement of Units 19
Median Technologies SA, Key Competitors 21
Median Technologies SA, Key Employees 22
Median Technologies SA, Other Locations 23
Median Technologies SA, Subsidiaries 23

List of Figures
Median Technologies SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Median Technologies SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Median Technologies SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Median Technologies SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Median Technologies SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Median Technologies SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Median Technologies SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Median Technologies SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Median Technologies SA (ALMDT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nexus AG (NXU):企業の財務・戦略的SWOT分析
    Summary Nexus AG (Nexus) is a healthcare technology company that provides healthcare software solutions. The company provides products such as NEXUS and HIS, a hospital information system; NEXUS and DIS, a special ward and department solutions; and NEXUS and QM, a solution in quality management, amo …
  • NanoString Technologies Inc (NSTG)-医療機器分野:企業M&A・提携分析
    Summary NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, ge …
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Alliant Energy Corporation:企業の戦略・SWOT・財務分析
    Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Transelectrica SA:企業の発電所・SWOT分析2018
    Transelectrica SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Israel Chemicals Ltd.:企業の戦略・SWOT・財務分析
    Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report Summary Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PT Adaro Energy Tbk:企業の戦略・SWOT・財務情報
    PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NiSource Inc.:企業の戦略・SWOT・財務情報
    NiSource Inc. - Strategy, SWOT and Corporate Finance Report Summary NiSource Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MRI Interventions Inc (MRIC):医療機器:M&Aディール及び事業提携情報
    Summary MRI Interventions Inc (MRI Interventions) is a medical equipment company that develops and commercializes platforms for performing invasive surgical procedures. The company’s products include systems used for performing invasive surgeries on brain and heart. Its products are used for treatin …
  • China Development Bank:企業の戦略・SWOT・財務情報
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hell Pizza:企業の戦略・SWOT・財務分析
    Hell Pizza - Strategy, SWOT and Corporate Finance Report Summary Hell Pizza - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Magenta Therapeutics Inc (MGTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Magenta Therapeutics Inc (Magenta Therapeutics) formerly HSCTCo Therapeutics Inc, is a clinical-stage biotechnology company focused on developing novel medicines which revolutionizes bone marrow transplant for treating autoimmune diseases, blood cancers and rare genetic diseases. Its product …
  • Mediobanca – Banca di Credito Finanziario SpA (MB):企業の財務・戦略的SWOT分析
    Mediobanca - Banca di Credito Finanziario SpA (MB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • AvStar Aviation Services Inc:企業の戦略的SWOT分析
    AvStar Aviation Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • DaVita Inc.:企業のM&A・事業提携・投資動向
    DaVita Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DaVita Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • JAKKS Pacific Inc (JAKK):企業の財務・戦略的SWOT分析
    Summary JAKKS Pacific Inc (JAKKS) is a consumer goods provider that designs, develops, produces and markets toys, leisure products and writing instruments for children and adults. The company’s products comprise dolls, role play and dress-up, halloween costumes, foot to floor ride-on vehicles, seaso …
  • Sulzer Ltd (SUN):企業の財務・戦略的SWOT分析
    Sulzer Ltd (SUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Noble Mineral Exploration Inc (NOB):企業の財務・戦略的SWOT分析
    Summary Noble Mineral Exploration Inc (Noble Mineral) is a mining and mineral exploration and development company that offers mineral resources. The company offers acquisition, exploration mining, production, and development of gold, nickel, copper, zinc, uranium, and mineral resources deposit prope …
  • Altin Yunus Cesme Turistik Tesisler A.S.:企業の戦略・SWOT・財務情報
    Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report Summary Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Rexahn Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Rexahn Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rexahn Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆